| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 31.23B | 29.74B | 29.87B | 30.17B | 28.44B |
| Gross Profit | 11.59B | 11.10B | 10.68B | 10.61B | 10.95B |
| EBITDA | 5.42B | 5.19B | 4.79B | 4.03B | 4.86B |
| Net Income | 2.96B | 2.91B | 2.63B | 2.06B | 2.76B |
Balance Sheet | |||||
| Total Assets | 67.01B | 64.64B | 62.54B | 60.38B | 59.23B |
| Cash, Cash Equivalents and Short-Term Investments | 24.59B | 22.35B | 21.77B | 20.12B | 20.50B |
| Total Debt | 0.00 | 208.10M | 298.05M | 340.97M | 112.10M |
| Total Liabilities | 8.16B | 8.06B | 7.92B | 7.60B | 7.84B |
| Stockholders Equity | 58.85B | 56.57B | 54.63B | 52.77B | 51.39B |
Cash Flow | |||||
| Free Cash Flow | 1.86B | 3.00B | 2.67B | 421.99M | 1.72B |
| Operating Cash Flow | 3.50B | 4.25B | 3.77B | 2.62B | 3.09B |
| Investing Cash Flow | -1.13B | -2.26B | -1.14B | -2.18B | -736.74M |
| Financing Cash Flow | -625.74M | -1.22B | -1.21B | -516.08M | -1.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥78.60B | 26.37 | ― | 1.12% | 5.01% | 1.83% | |
73 Outperform | ¥69.62B | 51.71 | ― | 1.52% | 6.15% | 73.57% | |
69 Neutral | ¥2.40T | 11.00 | 11.64% | 1.52% | 11.97% | 45.59% | |
69 Neutral | ¥557.92B | 21.11 | ― | 3.26% | 15.83% | 124.18% | |
63 Neutral | ¥395.07B | 13.04 | 13.71% | 3.38% | 0.16% | -12.55% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | ¥35.55B | 20.68 | ― | 3.70% | 29.30% | -82.16% |